Single‐cell multi‐omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK‐positive lung cancer

Related articles

1. Rictor CRISPR Gene Editing by Lipid Nanoparticle Delivery Stimulates Anti-tumor Immunity in Breast Cancer Liver Metastasis Model

   This article has 15 authors:

   1. Yaqoob Ali
   2. Tyler Galbraith
   3. Nourhan Abdelfattah
   4. Arturas Ziemys
   5. Thomas L Wong
   6. Chihiro Hashimoto
   7. Maryam Faisal
   8. Xu Qian
   9. Harlan Cook
   10. Tej Pandita
   11. Yitian Xu
   12. Roberto Rosato
   13. Shu-hsia Chen
   14. Kyuson Yun
   15. Fransisca Leonard

2. Cancer systems immunology reveals myeloid—T cell interactions and B cell activation mediate response to checkpoint inhibition in metastatic breast cancer

   This article has 16 authors:

   1. Edgar Gonzalez
   2. Jesse Kreger
   3. Yingtong Liu
   4. Xiaojun Wu
   5. Arianna Barbetta
   6. Aaron G. Baugh
   7. Batul Al-Zubeidy
   8. Julie Jang
   9. Sarah M. Shin
   10. Matthew Jacobo
   11. Vered Stearns
   12. Roisin M. Connolly
   13. Won Ho
   14. Juliet Emamaullee
   15. Adam L. MacLean
   16. Evanthia T. Roussos Torres

3. Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post Chemotherapy

   This article has 23 authors:

   1. Boris J.N. Winterhoff
   2. Nomeda Girnius
   3. Muyi Liu
   4. Jaeyoung Kang
   5. Mihir Shetty
   6. M. Angie Martinez-Gakidis
   7. Weiyi Xu
   8. Mayura Thomas
   9. Linna Lahmadi
   10. Aylin Z. Henstridge
   11. Pilar Baldominos
   12. Shobhana Talukdaer
   13. Zenas Chang
   14. Jordan Mattson
   15. Morgan Gruner
   16. Sally A. Mullany
   17. Peter Argenta
   18. Gottfried E. Konecny
   19. Dennis J. Slamon
   20. Ronny Drapkin
   21. Andrew C. Nelson
   22. Timothy K. Starr
   23. Joan S. Brugge